Status:
COMPLETED
The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Hyponatremia
Metabolic Bone Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The study investigates the association between normalization of serum sodium levels and bone markers in patients with epilepsy and chronic hyponatremia. The study is a randomized, single blinded, pla...
Eligibility Criteria
Inclusion
- Epilepsy requiring treatment for at least 2 years
- Known hyponatremia (2 subsequent s-sodium values \< 136 mmol/l)
- Age 18-80 years
- Danish speaking
- Signed form of prior consent
Exclusion
- Pregnancy and breastfeeding
- Known osteoporosis. DXA scan \< -2.5 T-score. Z-score is used for patients 50 years or younger.
- Undergoing treatment for osteoporosis
- Undergoing treatment with salt tablets
- Known SIADH
- Severe concomitant disease such as cancer or ischemic heart disease
- Alcohol, drug or substance abuse
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03371199
Start Date
December 1 2017
End Date
December 31 2018
Last Update
March 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet Glostrup
Glostrup Municipality, Denmark, 2600